Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000004678
- Lead Sponsor
- Keio University , School of Mecidicine, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Type 1 diabetes mellitus 2.Impaired renal function [serum-creatinine; =>1.5mg/dL(male), =>1.3mg/dL(female) or eGFR<30mL/min] 3.Severe liver dysfunction [AST, ALT=>3 fold above ULN] 4.Patients who are disqualified from the study by investigator for any reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method